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We have utilized the human hepatoceUular carcinoma cell line, Hep G2, to study the effects of low density iipoproteins 
(LDL), high density lipoproteins (HDL), and free cholesterol n apolipoprotein (apo) A-I mRNA levels. Incubation of 
the Hep G2 cells with LDL and free cholesterol led to a significant increase in the cellular content of cholesterol without 
any effect on the yield of total RNA or in the cellular protein content. Our studies established that incubation with LDL 
or free cholesterol increased the relative levels of apoA-I mRNA in the Hep G2 cells. In contrast with cholesterol loading, 
HDL had the effect of lowering the levels of apoA-I mRNA. These results indicate the LDL and HDL pathways as 
well as intracellular cholesterol may be important in apoA-I gene expression and regulation. 
HDL; Apolipoprotein A-I 
1. INTRODUCTION 
The human hepatocarcinoma cell line Hep G2, 
which retains many characteristics of the normal 
differentiated hepatocyte, synthesizes and secretes 
into the culture medium the majority of the human 
plasma apolipoproteins [1,2]. This cell line has 
been shown previously to be a good model system 
for studying the regulation of apolipoprotein 
biosynthesis, and the effects of estrogen on the 
secretion and mRNA levels of apoA-I and apoC-II 
have been well characterized [3-5]. 
Several different dyslipoproteinemias exhibit ab- 
normally high levels of LDL and low levels of 
HDL and apoA-I [6-8]. These observations sug- 
gest that the synthesis of LDL and HDL could be 
coordinately inked and the LDL receptor impor- 
tant in the regulation of apoA-I biosynthesis. In
the present study we have evaluated the effects of 
LDL, HDL, and free cholesterol on apoA-I 
mRNA levels in Hep G2 cells using a eDNA probe 
to quantitate specific mRNA levels by dot blot 
hybridization. LDL and free cholesterol led to an 
increase in the relative levels of apoA-I mRNA, 
whereas HDL had the opposite effect. These 
results indicate that intracellular cholesterol, as 
well as the LDL and HDL receptor pathways, may 
be linked to apoA-I gene expression and 
regulation. 
2. MATERIALS AND METHODS 
Correspondence address: J.M. Hoeg, Molecular Disease 
Branch, National Heart, Lung and Blood Institute, National 
Institutes of Health, Building 10, Room 7N117, Bethesda, MD 
20892, USA 
Abbreviations: apo, apolipoprotein; LDL, low density lipopro- 
reins; HDL, high density lipoproteins; MEM, Eagle's minimum 
essential medium; LPDS, lipoprotein deficient serum; PBS, 
phosphate-buffered saline; SSC, standard saline citrate 
2.1. Preparation of lipoproteins and LPDS 
LDL (d = 1.030-1.050 g/ml) and LPDS (d > 1.21 g/ml) 
were prepared from 500 ml of plasma collected in 0.1 °70 EDTA 
by plasmapheresis after a 12-14 h fast. Preparative ultracen- 
trifugation was performed at 4°C (24 h for LDL and 48 h for 
LPDS) utilizing KBr for density adjustment [9,10]. Isolated 
fractions were dialyzed against PBS. Protein concentration was 
determined as described by Lowry et al. [11], and cellular con- 
tent of cholesterol was quantitated by an enzymic fluorometric 
procedure [12]. 
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2.2. Cell culture 
The cell line Hep G2 was grown in T-150 flasks containing 
30 ml of MEM supplemented with 10070 fetal bovine serum. 
Cells were grown to near confluence prior to changing the 
media to serum supplemented with 10070 LPDS. After 24 to 48 h 
in MEM + LPDS the cells were changed to fresh MEM + LPDS 
(controls) or MEM + LPDS containing one of the following: 
LDL at a concentration f 200/zg protein/ml medium, HDL at 
a concentration of 50/Lg/ml medium, or cholesterol dissolved 
in absolute thanol (stock solution = 5 mg/ml) at a final con- 
centration of 50/~g/ml medium. 
2.3. Isolation of  total RNA 
At designated time intervals, culture media were removed and 
the cells monolayers were washed twice with 10 ml of ice-cold 
PBS. The cells were then harvested by addition of 4 ml of 4 M 
guanidinium thiocyanate [13] and removal with a cell scraper. 
The viscous cell suspension was homogenized using two pulses 
of 15 s each in a Polytron (Brinkman Instruments). 
2.4. cDNA probe 
A ds-cDNA probe was prepared by digestion with Mspl of 
the apoA-I cDNA clone as described [14]. This probe is 860 
base pairs in length and contains the entire sequence coding for 
mature apoA-I. The cDNA was labeled by nick translation with 
a [a)2p]CTP to a specific activity of approx. 3 x 108 dpm//zg 
[15]. 
2.5. Northern blot and dot blot analysis of  RNA 
Total RNA from Hep G2 cells was fractionated by 1°70 
agarose gel electrophoresis n the presence of 6070 for- 
maldehyde. Transfer of RNA to nitrocellulose was performed 
as described [16,17]. Quantitation of apoA-I mRNA was per- 
formed by dot blot hybridization [17]. Total RNA samples were 
diluted to a volume of 200/~1 using sterile doubly distilled water. 
Quadruplicate samples were spotted onto GeneScreen Plus 
membranes u ing a Schleicher and Schuell manifold. After bak- 
ing at 80°C for 2 h the filters were prehybridized in a solution 
containing 5 x SSC, 5 x Denhardt's olution, 0.1070 SDS, 
20 mM Na3PO4 (pH 7.0), 100/~g/ml salmon sperm DNA, and 
5007o formamide for 4-6 h at 42°C. Hybridization was per- 
formed for 48-72 h in 10 ml of the same solution containing 
the apoA-I cDNA probe (2 x 10~dpm/filter). Post- 
hybridization the filters were washed twice in 3 x SSC + 0.1 070 
SDS at room temperature for 30 min, twice in 1 x SSC + 0.107o 
SDS at 65°C for 30 min, and finally for 30 min in 0.2 x SSC 
at 65 °C. Filters were autoradiographed with Kodak XAR-5 film 
and double intensifying screens. Dot blots were quantitated 
with a laser scanning densitometer (LKB). 
3. RESULTS 
To  demonst ra te  the specif ic i ty o f  our  cDNA 
probe ,  tota l  RNA samples f rom human l iver, Hep  
G2 cells, and human f ibroblasts  were separated by 
1070 agarose gel e lectrophores is  and t rans fer red  on-  
to  n i t roce l lu lose by the Nor thern  blot  p rocedure  
(fig. 1, inset). Hybr id i za t ion  o f  the probe  to the 
n i t roce l lu lose f i lter revealed a single complemen-  
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Fig.l. Total RNA from Hep G2 cells was blotted in 
quadruplicate in the range from 2.5 to 10/@g and hybridized 
with the apoA-I cDNA probe. The filters were autoradio- 
graphed and quantitated in a laser scanning densitometer. 
Values represent mean _+ SD of triplicate samples. Inset 
illustrates Northern blot analysis of RNA from human 
fibroblasts, Hep G2 cells and normal human liver utilizing an 
apoA-I cDNA probe. A, 10/Lg total RNA from human 
flbroblasts; B, 10/zg total RNA from Hep G2 cells; C, 5/zg 
total RNA from normal human liver; D, 1/~g poly A + RNA 
from normal human liver. 
tary  mRNA species in the human l iver and in the 
Hep G2 cells, 950 bp in length.  A lso  i l lustrated is 
the cor re la t ion  o f  the levels o f  apoA- I  mRNA and 
tota l  RNA f rom Hep G2 cells quant i ta ted  by dot  
b lot  hybr id i za t ion  (fig. 1). Tota l  RNA was b lot ted 
in the range f rom 1 to 10/zg, and the assay was 
l inear f rom 1 to 5/zg o f  tota l  RNA.  Al l  subsequent  
studies to quant i ta te  relat ive levels o f  apoA- I  
mRNA were per fo rmed on total  RNA with in this 
range.  
S ince the cel lu lar  cholestero l  content  may p lay a 
ro le in the regulat ion  o f  apo l ipoprote in  b iosyn-  
thesis,  we quant i ta ted  the ef fect  o f  cholestero l  
de l ivery and incubat ion  with HDL  on the tota l  cell 
p ro te in  and cholestero l  concentrat ions  in Hep  G2 
cells. The  ef fects  o f  incubat ion  with LDL ,  HDL ,  
or  free cholestero l  d id not  alter the yields o f  total  
RNA and cel lu lar  prote in  content  (not shown).  In 
contrast ,  s igni f icant  changes were induced in the 
cel lu lar  content  o f  cholestero l  by LDL ,  HDL  and 
cho lestero l  as i l lustrated in table 1. 
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Table 1 
Effect of LDL, HDL and cholesterol on cellular content of 
cholesterol in Hep G2 cells after HDL (50 ~g/ml) preincubation 
Medium Cholesterol content 
(nmol/mg protein) 
Total Free Esterified 
0.4 
0.3 
< 
z 
0.2 
<C 
<C~ 0.1 
MEM + LPDS 56+ 13 46+ 9 a 12+ 6 
MEM + LPDS+ LDL 79+ 14 bc 54+ 13 d 24+ 7 e 
MEM + LPDS + HDL 50:1:14 bf 46 + 13 6 + 7 ¢ 
MEM + LPDS + 
cholesterol 116 :[: 15 cf 107 + 20 ad 11 + 12 
a-f Statistically significant differences (/7 < 0.05) between values 
designated with respective l tters 
The effects of LDL, HDL and free cholesterol 
on apoA-I mRNA levels in Hep G2 cells were 
evaluated by dot blot hybridization. HDL con- 
sistently decreased the relative levels of apoA-I 
mRNA, whereas cholesterol loading by either LDL 
or free cholesterol dissolved in ethanol increased 
apoA-I mRNA. The magnitude of the changes in 
apoA-I mRNA was found to be significantly in- 
fluenced by the pre-incubation conditions of the 
pre-confluent Hep G2 cells. Fig.2 illustrates the 
response of the apoA-I mRNA levels when the cells 
were pre-incubated for 24 h in MEM sup- 
plemented with 10% LPDS and then changed to 
fresh MEM + LPDS, MEM + LPDS + LDL, 
MEM + LPDS + HDL or MEM + LPDS + 
.---f 
Cholzsts~ LPDS LDL HDL 
HDL Cho les tero l  
Fig.2. Preconfluent Hep G2 cells were incubated for 24 h in 
MEM supplemented with 10% LPDS and then changed to fresh 
MEM + LPDS, MEM + LPDS + LDL, MEM + LPDS + HDL 
or MEM + LPDS + cholesterol. Bars represent the mean =t= SD 
of quadruplicate samples. 
cholesterol (dissolved in ethanol). ApoA-I mRNA 
levels were increased by LDL and cholesterol com- 
pared with the cells grown in MEM + LPDS. In 
contrast, HDL induced a small decrease in apoA-I 
mRNA levels but the results did not reach 
statistical significance. However, the difference 
between the effects of HDL (decrease) and LDL or 
cholesterol (increase) was significant. 
The magnitude of the changes in apoA-I mRNA 
levels was greater when the cells were pre- 
incubated for 24 h in MEM + LPDS containing 
HDL at a concentration of 50/Lg protein/ml 
medium; these results are illustrated in fig.3. LDL 
and cholesterol induced an approximately 20o70 in- 
crease in apoA-I mRNA levels. The decrease in the 
mRNA levels associated with HDL was in this case 
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Fig.3. Preconfluent Hep G2 cells were preincubated for 24 h in 
MEM + LPDS containing HDL at a concentration of 50/~g 
protein/ml medium before changing the media. Bars represent 
the mean =l= SD of quadruplicate samples. 
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Fig.4. Hep G2 cells were incubated in MEM + LPDS 
containing 200/zg protein/ml medium of LDL followed by the 
addition of the different types of media as indicated. Bars 
represent the mean + SD of quadruplicate samples. 
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greater than 40°70. A comparison between the 
apoA-I mRNA levels following incubation with 
HDL with the incubations with LDL or free 
cholesterol demonstrated an even greater dif- 
ference, with cholesterol loading by either method 
being associated with levels that were at least 
2-fold higher than with HDL. In contrast with 
these results, minimal changes were observed when 
the pre-incubation conditions were 24 h in MEM + 
LPDS containing 200/zg/ml of LDL protein 
(fig.4). Interestingly, further incubation in the 
presence of media containing LDL did not increase 
the apoA-I mRNA levels. Time course xperiments 
were also carried out to further characterize the 
response of apoA-I mRNA levels to HDL. There 
was a decrease in apoA-I in RNA levels within 2 h 
after the addition of HDL (not shown). Therefore, 
the modulation of apoA-I mRNA by HDL was 
rapid and sustained up to 24 h. 
4. DISCUSSION 
The liver plays a major role in virtually every 
aspect of lipoprotein synthesis and catabolism 
[18]. VLDL, HDL and the majority of the known 
apolipoproteins are synthesized by the liver. 
Kinetic studies have led to great advances in our 
understanding of lipoprotein and apolipoprotein 
biosynthesis [19]. However, because of the limita- 
tions with the availability of human cells, the basic 
molecular mechanisms responsible for those pro- 
cesses have not been fully defined. 
In the studies reported here we have utilized the 
Hep G2 cells as a model system to evaluate the ef- 
fects of LDL, free cholesterol and HDL on the 
levels of apoA-I mRNA. We have established that 
cholesterol loading, either by LDL uptake or addi- 
tion of free cholesterol to the media, led to a 
significant accumulation of cholesterol within the 
cells, without significantly affecting cell growth or 
number when compared with control cells in- 
cubated in MEM supplemented with LPDS. Both 
LDL uptake and free cholesterol loading were 
associated with an increase in the levels of apoA-I 
mRNA in the Hep G2 cells. In contrast, HDL led 
to a 37-57070 decline in intracellular total and a 
45-75070 reduction in free cholesterol compared to 
LDL treated cells. These changes in cellular sterol 
content were associated with a decrease in the 
levels of apoA-I mRNA. 
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The mechanisms of the increased apoA-I levels 
with cholesterol loading and their decrease by 
HDL remain to be elucidated. It is very likely that 
there are distinct intracellular pools of cholesterol 
with different functions. In these studies only the 
total content of cholesterol per cell was quan- 
titated. In addition the pathways (e.g. LDL recep- 
tor, HDL receptor, or alternate) that cholesterol 
utilizes to enter or exit the cell may be of great im- 
portance and ultimately determine the effect(s) of 
cholesterol in the regulation of apolipoprotein 
biosynthesis. 
In the Hep G2 cells, as in any other system, the 
levels of a particular mRNA species may be deter- 
mined by several factors. The changes in apoA-I 
mRNA levels induced by cholesterol loading or 
HDL could be due to modifications at the level of 
the transcriptional rate resulting from the interac- 
tion of regulatory elements in the apoA-I gene with 
a trans-acting regulatory ligand. Other potential 
sites of regulation are at the level of processing of 
the primary transcript and at the mechanisms that 
control the stability of the mRNA [20]. 
The results of the present study provide addi- 
tional insights in our understanding of HDL and, 
in particular, apoA-I metabolism. Another poten- 
tial implication of our results relates to the 
mechanism whereby certain drugs increase the 
plasma levels of HDL and apoA-I [21]. Drugs like 
lovastatin and niacin, by up-regulating the LDL 
receptor lead to increased uptake of LDL which 
could then be followed by an increase in apoA-I 
mRNA levels and, consequently, by an enhanced 
synthetic rate of apoA-I and HDL. Further studies 
will be necessary to test these and other 
hypotheses, and to further understand the 
mechanisms regulating the cellular levels of apoA-I 
mRNA. 
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